Skip to content
Screener

Biogen BIIB Q1 2025 earnings

Reported May 1, 2025 · Before market open

Revenue$2.4BBeat by $196.8M
EPS$3.02Beat by $0.12
Revenue estimate$2.2B
EPS estimate$2.90

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$2.6B
EPS estimate$2.04

Financials

Q1 2025

Income statement

See full
Revenue$2.4B+6.1%
Gross profit$1.8B+3.1%
Net income$240.5M-38.9%
EPS (diluted)$1.64-39.3%

Balance sheet

See full
Cash & equivalents$2.6B+142%
Total debt$4.9B-27.2%
Total equity$17.0B+11.6%
Total assets$28.0B+5.5%

Cash flow

See full
Operating cash flow$259.3M-53.1%
CapEx$37.1M-19.2%
Free cash flow$222.2M-56.2%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$20.03B-36.1%
Enterprise value$22.3B-39.7%
P/E13.5×-13.3×
P/S2×-1.2×

Profitability

See full
Gross margin75.6%+0.5pp
Net margin15.1%+3.0pp
FCF margin24.8%+9.9pp

Returns & leverage

See full
Return on equity9.2%+1.1pp
Debt / equity0.3×-0.2×
Current ratio1.4×-0.7×

Segments

By product

See full
SPINRAZA$423.9M+24.2%
TYSABRI$381.5M-11.5%
TECFIDERA$206.1M-19.0%
AVONEX$166.8M-6.6%
VUMERITY$138.8M+8.9%

By segment

See full
Reportable Segment$2.4B+6.1%

FAQ

When did Biogen report Q1 2025 earnings?
Biogen (BIIB) reported Q1 2025 earnings on May 1, 2025 before market open.
What were Biogen's Q1 2025 revenue and EPS?
Biogen reported revenue of $2.4B and eps of $3.02 for Q1 2025.
Did Biogen beat estimates in Q1 2025?
Revenue beat the consensus estimate of $2.2B by $196.8M. EPS beat the consensus estimate of $2.90 by $0.12.
How did Biogen's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.5% from $2.2B a year earlier and eps declined 17.7% from $3.67.
Where can I find Biogen's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000875045-25-000014) and the 10-Q periodic report (0000875045-25-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.